Previous studies found that the expression of SELENBP1 was dramatically downregulated in human cancer tissues including thyroid cancer, lung cancer, liver cancer, gastric cancer, kidney cancer and so on, and the downregulated expression of SELENBP1 was associated with the progression and poor prognosis of various cancers.11, 17. This evidence concerns the gene SELENBP1 and liver cancer.